Steve L. Abrams
Impact in
-
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- PI3K/AKT/mTOR signaling in cancer
- Epigenetics and DNA Methylation
- Hedgehog Signaling Pathway Studies
-
- MicroRNA in disease regulation
Papers in
-
- Wnt/β-catenin signaling in development and cancer 2
- Hedgehog Signaling Pathway Studies 2
- Biochemical and Molecular Research 1
-
- Quinazolinone synthesis and applications 2
- Co-authors
- James A. McCubrey (8 shared papers)Linda S. Steelman (6 shared papers)Lucio Cocco (5 shared papers)Alberto M. Martelli (7 shared papers)Massimo Libra (5 shared papers)Agnieszka Gizak (3 shared papers)Melchiorre Cervello (3 shared papers)Giuseppe Montalto (3 shared papers)
- Journals
- Blood (3 papers)Oncotarget (2 papers)Advances in Biological Regulation (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)Expert Opinion on Therapeutic Targets (1 paper)
- Partner nations
- United StatesItalyPoland
In The Last Decade
Steve L. Abrams
8 papers receiving 621 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 444
- Cancer Research 82
- Oncology 135
- Geriatrics and Gerontology 15
- Molecular Medicine 19
Countries citing papers authored by Steve L. Abrams
This map shows the geographic impact of Steve L. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve L. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve L. Abrams more than expected).
Fields of papers citing papers by Steve L. Abrams
This network shows the impact of papers produced by Steve L. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve L. Abrams. The network helps show where Steve L. Abrams may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve L. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 398 | |
| 2 | 2016 | 131 | |
| 3 | 2017 | 44 | |
| 4 | 2005 | 41 | |
| 5 | 2017 | 7 | |
| 6 | 2007 | 2 | |
| 7 | 2007 | 1 | |
| 8 | 2007 | 1 |
About Steve L. Abrams
Steve L. Abrams is a scholar working on Molecular Biology, Organic Chemistry, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 625 indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Hedgehog Signaling Pathway Studies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), MicroRNA in disease regulation (1 paper), Curcumin's Biomedical Applications (1 paper), Biochemical and Molecular Research (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Molecular Biology (444 citations), Cancer Research (82 citations), Oncology (135 citations), Geriatrics and Gerontology (15 citations) and Molecular Medicine (19 citations). Steve L. Abrams has collaborated with scholars based in United States, Italy and Poland. Frequent co-authors include James A. McCubrey, Linda S. Steelman, Lucio Cocco, Alberto M. Martelli, Massimo Libra, Agnieszka Gizak, Melchiorre Cervello, Giuseppe Montalto, Dariusz Rakus and Ferdinando Nicoletti. Their work appears in journals such as Blood, Oncotarget, Advances in Biological Regulation, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.